Skip to main content
. 2013 Nov;87(21):11659–11669. doi: 10.1128/JVI.01434-13

Fig 1.

Fig 1

PABP1 localization during RVFV infection. (A) Immunofluorescence assay of cells infected with RVFV MP12 or mock infected for 24 h and then fixed and stained for PABP1 and RVFV N. (B) Immunofluorescence assay of RVFV MP12-infected HeLa cells. Cells were infected for 0, 4, or 6 h and then fixed and stained for PABP1 (red in overlay) and RVFV N (green in overlay). (C) Immunofluorescence assay of mock-infected, RVFV-infected, Hantaan virus-infected, or Andes virus-infected A549 cells fixed and stained for nucleocapsid and PABP1. RVFV-infected samples were fixed at 24 h postinfection. Mock-infected, Hantaan-infected, and Andes-infected samples were fixed at 72 h postinfection.